<DOC>
	<DOCNO>NCT00605163</DOCNO>
	<brief_summary>The purpose study longitudinally follow consent clinical trial participant participate PRECEPT ( A Randomized , Double Blind , Placebo Controlled , Dose Finding Study Assess Efficacy Safety CEP 1347 Patients With Early Parkinson 's Disease ) . The study assess clinical imaging outcome relevant natural history Parkinson 's disease ( PD ) , well determine early biomarkers disease .</brief_summary>
	<brief_title>A Longitudinal Observational Follow-up PRECEPT Study Cohort</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Participation PRECEPT study Willing able give inform consent Patients exclude participate study either criterion state met</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Parkinson disease , observational , longitudinal</keyword>
</DOC>